Research Design Service: East Midlands

Latest News

Changes/updates to the SAF, with some specific changes relating to PPI

  Created on Tuesday, 30 Jun 2020. Posted in Public Involvement | Funding

Stage 1

  • Inclusion of public co-applicants, where appropriate, with a clear description of their role and the reasons why a public co-applicant is joining the team
  • PPI Lead - There should be a named person with appropriate skills and experience who is responsible for leading the PPI element within the project. This role should be an adequately costed and resourced research team member who is able to manage the PPI plans and related activities.
  • Justification of health/care need - Identify how will the public/patients see this as a need and as a potential improvement to their health and/or lives? 
  • Project Plan (Patient and Public Involvement):

o   show your plans for involving patients/service user, carers and the public at each appropriate stage of the research project lifecycle

o   outline how PPI has informed the development of the project so far, including how it has specifically shaped the research question and study design 

  • Dissemination plans: include details of how you will share with study participants the progress and findings of the study (PPI could inform this)

Stage 2

As stage 1, but also:

  • PPI Section:
  1. NEW PPI approach, management and support section to include:
  • why your approach to patient and public involvement is appropriate, including who will be involved and why
  • how you plan to manage and coordinate the patient and public involvement activities
  • how you will support and enable patients/service users, carers, the public and members of relevant communities to contribute to your research (e.g. access, payments, training).
  • outline plans for the capturing, evaluating and reporting the impact of patient and public involvement activities
  1. NEW Summary of PPI activities, including
  • a summary of the proposed PPI activities embedded throughout the research project lifecycle
  • clearly signpost to other sections of the Detailed Research Plan where the PPI is described further in relation to the relevant project stage
  • Costings - If voluntary, charity or community groups are supporting the research via activities such as facilitating contact with potential participants, hosting research activities or providing advice, an adequate budget must be included to compensate for their time and resources.

 


Recruiting participants for adult social care studies: challenges and mitigating strategies METHODS REVIEW

  Created on Monday, 22 Jun 2020. Posted in Guidance | Social Care

This Methods Review aimed to describe the challenges in recruiting organisations and individuals for adult social care research and identify possible strategies to address them.

One of the main barriers to recruitment was variation among provider organisations, so recruitment strategies needed to be adjusted for different organisations, many of which lacked capacity for research participation. The rapidly changing nature of adult social care organisation and delivery in England also means that recruitment strategies often need to be adapted while research is in progress. Building partnerships between researchers and providers and offering financial and other incentives were suggested as mitigating strategies. In recruiting individuals, a lack of understanding of research benefit and organisations’ gatekeeping arrangements were common difficulties. Interviewees suggested: raising public awareness of adult social care research; building relationships with user/carer groups; using a variety of recruitment strategies and offering a range of participation routes. Researchers and funding bodies should allow sufficient time and resources to recruit representative samples. Researchers should share recruitment knowledge.


Covid-19 rapid response research calls: views from public contributors

  Created on Wednesday, 10 Jun 2020. Posted in Public Involvement

  • Due to the short turnaround time of one year, the public will want to know what the impact of the study will be on people and communities - what difference will the research make to our lives?
  • Lab based studies particularly can benefit from developing a dissemination strategy. The public have a right to know about the impact the research makes and there is also interest for this to happen more meaningfully and at scale.
  • Research applicants don’t always demonstrate how they plan to engage and involve people and communities in their study even if they are already doing it - put it in the form.
  • Research applicants who have access to established PPIE groups and networks tend to have stronger PPI input in their application - if you don’t have existing groups to reach out to, you can access Covid research specific PPIE groups through the HRA UK Covid-19 PI in Research database
  • NIHR has an expectation that there is PPI in every research study, indeed it's listed in the guidance document for the call.
  • Applicants need to demonstrate more robustly how they plan to reach out to people and communities from diverse backgrounds particularly from BAME communities, recognizing that this is not a homogenous group.
  • Some of the applications are lab-based or involve animals, which is new to some reviewers. Appreciate that PPI is challenging in basic research,and tight timeframe doesn’t allow researchers to learn about PPI. Some of them seem to think that they don’t need to do PPIE. Every case they could have done PPIE had they had the time, resources, inclination.
  • Where an application is low in detail, it is usually low in plans for PPIE too.
  • This is a great opportunity to dissemination. Lab-based researchers who don’t build in PPI miss the point of what the general public is concerned about.
  • Reasonable amount of PPI at the beginning, since then reduction, not sure why this is happening but concerning. Seems to be happening everywhere - HRA, ethics committees are also seeing less PPI.
  • Some applicants use the science as an ‘excuse’ for not having PPI. Understand if it’s not possible in the science part but the overarching governance, consent over samples should not be missing.
  • Feeling in the PPI area that PPI is still an add-on; some researchers still think that when they need to be speedy, PPI can be dropped.
  • Disconnect between seeing patients as participants and thinking that is PPI.

Reimagining research - Wellcome report

  Created on Tuesday, 19 May 2020. Posted in Literature

Wellcome has published a report, What researchers think about the culture they work in. The results are based on a survey of more than 4,000 researchers in the UK and globally, and nearly 100 in-depth interviews.


Equality, diversity and inclusion in Patient and Public Involvement and Engagement

  Created on Tuesday, 12 May 2020. Posted in Public Involvement | EDI

As part of NIHR's commitment to actively and openly supporting and promoting equality, diversity, and inclusion (EDI) they've produced new Standard Application Form (SAF) guidance that includes improved requirements to will strengthen EDI and patient, public involvement and engagement (PPIE).


Core outcome set - response to COVID-19

  Created on Friday, 01 May 2020. Posted in Priorities | Methods

Many clinical trials and systematic reviews are already underway, or will begin shortly, to strengthen the evidence base for the COVID-19 response. Core outcome sets (COS), showing the outcomes that should be measured and reported in these studies, will ensure that this evidence base will contain, as a minimum, the key information needed by decision makers about the effects of interventions.

COMET core outcome sets for trials and systematic reviews


COVID-19 Research and Platform (Complex Innovative Design) Trials

  Created on Thursday, 30 Apr 2020. Posted in Methods

A Platform study allows for several experimental treatments to be studied simultaneously. In addition, new experimental treatments can be integrated into an existing study rather than setting up a new study. This allows for more efficient research


Insights into adaptive studies and other complex and novel methods

  Created on Thursday, 30 Apr 2020. Posted in Methods

Research and Development Forum's slides from their Research but not as we know it: Managing novel methods in research symposium (March 2020)


A framework for considering who might be involved in research

  Created on Wednesday, 01 Apr 2020. Posted in Public Involvement

New INVOLVE guidance to be used as a framework to help make decisions about which public contributors you might involve in your research and why.

  • There should always be clarity about the purpose of involving specific individuals or groups
  • Including a diversity of views and perspectives often helps to improve the research
  • Review the way the involvement role and opportunity has been structured to ensure there are not unintended barriers stopping other public contributors from engaging
  • People can wear several hats and their contributions may be broader because of the range of their expertise
  • The type of lived experience needed will vary depending on the focus of the research

 


UK Government commits £12million to research into preventable diseases

  Created on Tuesday, 17 Mar 2020. Posted in Funding

The UK Government has committed an extra £12million to the National Institute for Health Research in 2020/21 for research into preventable diseases. Heart disease, diabetes, chronic respiratory diseases and cancer are all linked to preventable causes and contribute to slowing improvements in life expectancy, and regional and socio-economic inequalities in health outcomes. This new investment will be directed particularly towards Local Authorities, helping them grow and support their research capabilities so they can work further to solve a range of major preventable health challenges. The aim is that this will support the Government’s work to increase healthy life expectancy by 5 years by 2035, while narrowing the gap between the experience of the richest and poorest.